New hope for toddlers with rare hormone disorder?
Disease control
Recruiting now
This study tests a drug called crinecerfont in 20 children aged 3 months to 4 years with classic congenital adrenal hyperplasia (CAH). The goal is to see if the drug is safe and tolerable. Participants must already be on stable hydrocortisone treatment. The study is not yet recru…
Phase 2 • Sponsor: Neurocrine Switzerland GmbH • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC